Upbeat Update from Duke on Stem Cell Autism Trial

This week at the World Stem Cell Summit, Dr. Joanne Kurtzberg, Pediatric Bone Marrow Transplant Specialist at Duke University Medicine, gave an encouraging update on the use of umbilical cord blood stem cells to treat autism. The data presented seem very encouraging. In addition to evidence of efficacy, the cord blood transplants were reported to be safe so that’s encouraging as well.. She reported improvements with cord blood treatment of autistic patients across a number of readout assays (p values in parentheses): decreased sensory sensitivity (0.03), increased social communication (0.007), decreased repetitive behavior (0.01) and a decrease in social withdrawal although not significant (0.09).

Read More